New test aims to spot dangerous uterine tumors before surgery
NCT ID NCT04250766
Summary
This study is testing a special biopsy procedure to see how well it can tell the difference between a common, non-cancerous uterine fibroid and a rare, dangerous cancer called a sarcoma before a patient has surgery. Doctors want to know if this biopsy can accurately identify the cancer so they can avoid a surgical technique that might spread it. The study involves 19 women in France who have suspicious uterine tumors that require surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROID UTERUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Bergonié
Bordeaux, 33076, France
Conditions
Explore the condition pages connected to this study.